Profile data is unavailable for this security.
About the company
Vivoryon Therapeutics NV is a Germany-based clinical-stage biopharmaceutical company with focus on the research and development of new therapeutic products for the treatment of Alzheimer’s disease (AD) and other diseases with high medical need like Cancer and Fibrosis. The Company is developing a directed pipeline of product candidates with the project being a therapeutic approach for the treatment of AD. Its operations focus on the discovery and development of therapeutic programs, whereas operational research and development work is mainly outsourced to respective professional contract research organizations (CROs) or academic collaboration partners. Vivoryon strives to generate future revenues from licensing its product candidates to biopharmaceutical companies after development steps have been achieved or by commercializing products.
- Revenue in EUR (TTM)-3.62m
- Net income in EUR-31.19m
- Incorporated--
- Employees15.00
- LocationVivoryon Therapeutics NVWeinbergweg 22HALLE 06120GermanyDEU
- Phone+49 3 455559900
- Fax+49 3 455559901
- Websitehttps://www.vivoryon.com/